iomx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-admin/ Allow:
Meta Tags
Title iOmx
Description Developing next-generation targeted cancer immunotherapy We discover and develop next-generation targeted immunotherapy treatments for cancer patients. antibody, cancer, signaling cascades, shut-down,
Keywords N/A
Server Information
WebSite iomx faviconiomx.com
Host IP 107.180.21.70
Location United States
Related Websites
Site Rank
More to Explore
islamicsm.com
jabx.net
jaipurskoka.com
jennyflores.com
jewellshewell.com
jjlpm.com
journeysystems.com
kabayan.com
kcconcretecontractors.com.au
keystone-foundation.org
khonsevse.com
kingston-college.ac.uk
klmehtadayanandschoolssec16.net
kouponkaren.com
krishnaoffice.com
kritiinstitute.com
kscastinggroup.com
kuberagrotech.com
kuberudyog.com
kydonhotel.com
iomx.com Valuation
US$918,659
Last updated: 2023-05-07 06:44:17

iomx.com has Semrush global rank of 11,521,481. iomx.com has an estimated worth of US$ 918,659, based on its estimated Ads revenue. iomx.com receives approximately 106,000 unique visitors each day. Its web server is located in United States, with IP address 107.180.21.70. According to SiteAdvisor, iomx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$918,659
Daily Ads Revenue US$848
Monthly Ads Revenue US$25,440
Yearly Ads Revenue US$305,278
Daily Unique Visitors 7,067
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
iomx.com. A 7199 IP: 107.180.21.70
iomx.com. NS 3600 NS Record: ns35.domaincontrol.com.
iomx.com. NS 3600 NS Record: ns36.domaincontrol.com.
iomx.com. MX 3600 MX Record: 0 iomx-com.mail.protection.outlook.com.
iomx.com. TXT 3600 TXT Record: MS=ms29623550
iomx.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-07 06:44:17
Technology Pipeline About us Investors News Careers Contact © iOmx 2023 Imprint / Impressum Privacy Policy / Datenschutzerklärung Developing next-generation targeted cancer immunotherapy treatments iOmx Therapeutics focuses on the development of next-generation, first-in-class cancer immune-checkpoint inhibitors. By systematically screening human tumor cells, the Company has identified a number of novel targets and is building a pipeline of drug candidates against them. The Company was founded on the successful concept of cancer immune-checkpoint therapy, which works by breaking down the inherent resistance mechanisms of tumors against immune attack. Reactivating the host immune response by neutralizing these negative interactions is the key idea behind cancer immune-checkpoint therapy. Discover our
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 13:01:14 GMT
Server: Apache
X-Powered-By: PHP/7.3.30
Upgrade: h2,h2c
Connection: Upgrade
Location: https://iomx.com/
Vary: User-Agent
Referrer-Policy: 
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
x-powered-by: PHP/7.3.30
link: ; rel="https://api.w.org/"
vary: User-Agent
referrer-policy: 
content-type: text/html; charset=UTF-8
date: Wed, 27 Oct 2021 13:01:14 GMT
server: Apache
iomx.com Whois Information
Domain Name: IOMX.COM
Registry Domain ID: 85847954_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-04-23T13:22:11Z
Creation Date: 2002-04-22T17:44:31Z
Registry Expiry Date: 2023-04-22T17:44:31Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS35.DOMAINCONTROL.COM
Name Server: NS36.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T10:00:38Z <<<